Evidence map›Paper›PMID 30988385›Full record

ArticleScientific reports2019

Kynurenic acid as the neglected ingredient of commercial baby formulas.

Pawel Milart, Piotr Paluszkiewicz, Piotr Dobrowolski, Ewa Tomaszewska, Katarzyna Smolinska, Iwona Debinska, Kinga Gawel, Katarzyna Walczak, Jerzy Bednarski, Monika Turska and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Effect ofPeerJ · 2023
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Tryptophan Derivatives byInternational journal of molecular sciences · 2021
    Article
  13. Article
  14. Article
  15. Kynurenic acid and cancer: facts and controversies.Cellular and molecular life sciences : CMLS · 2020
    Review
  16. Kynurenic acid selectively reduces heart rate in spontaneously hypertensive rats.Naunyn-Schmiedeberg's archives of pharmacology · 2020
    Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Pawel Milart3rd Department of Gynecology, Medical University of Lublin, Jaczewskiego 8, PL-20090, Lublin, Poland. pawel.milart@umlub.pl.
Piotr PaluszkiewiczDepartment of General, Oncological and Metabolic Surgery Institute of Haematology and Transfusion Medicine, Indiry Gandhi 14, PL-02776, Warsaw, Poland.
Piotr DobrowolskiDepartment of Comparative Anatomy and Anthropology, Maria Curie-Sklodowska University, Akademicka 19, PL-20033, Lublin, Poland.ORCID http://orcid.org/0000-0001-5873-9666
Ewa TomaszewskaDepartment of Animal Physiology, University of Life Sciences in Lublin, Akademicka 12, PL-20950, Lublin, Poland.
Katarzyna SmolinskaDepartment of Surgery and Surgical Nursing, Medical University of Lublin, Szkolna 18, PL-20124, Lublin, Poland.
Iwona DebinskaDepartment of Surgery and Surgical Nursing, Medical University of Lublin, Szkolna 18, PL-20124, Lublin, Poland.
Kinga GawelDepartment of Experimental and Clinical Pharmacology, Medical University of Lublin, Jaczewskiego 8b, PL-20090, Lublin, Poland.ORCID http://orcid.org/0000-0001-8857-847X
Katarzyna WalczakDepartment of Pharmacology, Medical University of Lublin, Chodzki 4a, PL-20093, Lublin, Poland.
Jerzy BednarskiChair of Human Anatomy (Department of Normal Anatomy), Medical University of Lublin, Jaczewskiego 4, PL-20090, Lublin, Poland.ORCID http://orcid.org/0000-0002-0186-3268
Monika TurskaDepartment of Pharmacology, Medical University of Lublin, Chodzki 4a, PL-20093, Lublin, Poland.
Michal Raban2nd Chair and Department of General and Gastrointestinal Surgery and Surgical Oncology of the Alimentary Tract, Medical University of Lublin, Staszica 16, PL-20081, Lublin, Poland.
Tomasz KockiDepartment of Experimental and Clinical Pharmacology, Medical University of Lublin, Jaczewskiego 8b, PL-20090, Lublin, Poland.
Waldemar A TurskiDepartment of Experimental and Clinical Pharmacology, Medical University of Lublin, Jaczewskiego 8b, PL-20090, Lublin, Poland.ORCID http://orcid.org/0000-0002-5805-5106
Medical University of Lublin · PLMaria Curie-Skłodowska University · PLUniversity of Life Sciences in Lublin · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global increase in resorting to artificial nutritional formulas replacing breastfeeding has been identified among the complex causes of the obesity epidemic in infants and children. One of the factors recently recognized to influence metabolism and weight gain is kynurenic acid (KYNA), an agonist of G protein-coupled receptor (GPR35). Therefore the aim of the study was to determine the concentration of KYNA in artificial nutritional formulas in comparison with its level in human breast milk and to evaluate developmental changes in rats exposed to KYNA enriched diet during the time of breastfeeding. KYNA levels were measured in milk samples from 25 heathy breast-feeding women during the first six months after labor and were compared with 21 time-adjusted nutritional formulas. Animal experiments were performed on male Wistar rats. KYNA was administered in drinking water. The content of KYNA in human milk increases more than 13 times during the time of breastfeeding while its level is significantly lower in artificial formulas. KYNA was detected in breast milk of rats and it was found that the supplementation of rat maternal diet with KYNA in drinking water results in its increase in maternal milk. By means of the immunoblotting technique, GPR35 was evidenced in the mucosa of the jejunum of 1-day-old rats and distinct morphological changes in the jejunum of 21-day-old rats fed by mothers exposed to water supplemented with KYNA were found. A significant reduction of body weight gain of rats postnatally exposed to KYNA supplementation without changes in total body surface and bone mineral density was observed. The rat offspring fed with breast milk with artificially enhanced KYNA content demonstrated a lower mass gain during the first 21 days of life, which indicates that KYNA may act as an anti-obesogen. Further studies are, therefore, warranted to investigate the mechanisms regulating KYNA secretion via breast milk, as well as the influence of breast milk KYNA on mass gain. In the context of lifelong obesity observed worldwide in children fed artificially, our results imply that insufficient amount of KYNA in baby formulas could be considered as one of the factors associated with increased mass gain.

Indexed as

AnimalsBreast FeedingDietary SupplementsDisease Models, AnimalFemaleGastrointestinal TractHumansInfantInfant FormulaInfant, NewbornInfant Nutritional Physiological PhenomenaKynurenic AcidMaleMetabolic Networks and PathwaysMilk, HumanObesityKynurenic Acid

Identifiers

PMID30988385
PMCPMC6465401
OpenAlexW2936850979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.